ARCHIVES

DCT Board Insists On Being Heard In Development Of CCOP Guidelines

This article is from The Cancer Letter archive.

Vol. 08 No. 08 | February 19, 1982

Download PDF Visit The Full Archive

Related Articles

In Setback For Generics, Court Overturns FDA.

November 9, 2001

In Brief: Shubik, Rhoads, Dixon Affiliations With Industry Lister By House Subcommittee

June 11, 1976

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

Tobacco Interests Contribute a Portion Of the $109 Million Raised by Stand Up To Cancer

September 12, 2014

CCOP Recompetition Approved By NCAB

May 23, 1986

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991